Other Resources

Galveston National Laboratory The GNL is an academic research center located at the University of Texas Medical Branch in Galveston, TX. With specialized programs in aerobiology, assay development, experimental pathology, imaging, insectary services, preclinical studies in laboratory animals from mice to non-human primates, and a special emphasis on BSL4 pathogens, the GNL offers collaborative services at all containment levels for the discovery and testing of diagnostics, treatments and vaccines directed against infectious diseases.
NIAID Research Resources This site provides links to many NIAID resources relevant to the RCE mission.  Selected items of interest are listed separately below.
	BEI Resources BEI Resources is managed under contract by ATCC to provide reagents, tools, and information for studying Category A-C priority pathogens and emerging infectious disease agents, as well as other biological materials of relevance to the research community.  BEI Resources also encourages and supports the deposit of materials from researchers and institutions, providing secure storage, community access, and distribution while also protecting depositors' intellectual property rights.
	Microbial Sequencing Centers The goal of these centers is to provide rapid, cost-efficient production of high-quality genome sequences of Category A-C priority pathogens and invertebrate vectors of disease. The centers also offer genotyping platforms to identify genes that play a role in virulence, host-pathogen interaction, and host susceptibility to infectious diseases.  NIAID will accept and review requests from investigators in academia, not-for-profit organizations, industry, and other government agencies worldwide for microbial genome sequencing and genotyping services.
	Preclinical Development Services Preclinical services to support the development of promising diagnostic, therapeutic, and vaccine candidates, including lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; preclinical development planning and evaluation; and regulatory support.
	NIH Rapid Access to Interventional Development (NIH-RAID) Similar to the National Cancer Institute’s RAID program, the NIH-RAID program makes available, on a competitive basis, certain critical resources needed for the development of new therapeutic agents. Services provided will depend upon the stage of the project and the strength of the preliminary data. Services available include: production, bulk supply, GMP manufacturing, formulation, development of an assay suitable for pharmacokinetic testing, and animal toxicology. Assistance also will be provided in the regulatory process, through access to independent product development planning expertise. Proposals in support of animal efficacy studies or synthesis and formulation of recombinant proteins or monoclonal antibodies will not be accepted.
	Trans NIAID Clinical Research Toolkit The Trans NIAID Clinical Research Toolkit (CTK) is an internet-based information repository for all NIAID staff and extramural investigators involved in clinical research. The CTK will provide a single portal through which authoritative information, such as standard protocol templates, Good Clinical Research Practices (GCP) training, clinical research databases, and policies and Standard Operating Procedures (SOPS) can be readily accessed.